SCHEMBL8294530

SCHEMBL8294530

C=CS/C=C\C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL664383 0.76
SCHEMBL10347089 0.76
SCHEMBL664382 0.76
SCHEMBL28752347 0.72
SCHEMBL2554926 0.69
SCHEMBL8770964 0.69
SCHEMBL17130560 0.69
SCHEMBL50200 0.66
SCHEMBL18896651 0.65
SCHEMBL12163373 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2976327-B1 3-ACETYLAMINO-1-(PHENYL-HETEROARYL-AMINOCARBONYL OR PHENYL-HETEROARYL-CARBONYLAMINO)BENZENE DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS Bayer Pharma AG (DE) 2017-06-21 EP disclosed
EP-2411986-B1 DIKETOPYRROLOPYRROLE POLYMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES BASF SE (DE) 2016-09-21 EP disclosed
EP-2816092-A1 New conductive and photosensitive polymers Nano And Advanced Materials Institute Limited (CN) 2014-12-24 EP disclosed
EP-2332912-A1 Heteroarylaminosulfonylphenylderivates for use as sodium or calcium channel blockers in the treatment of pain VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-15 EP disclosed
EP-2327701-A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-01 EP disclosed
EP-1370629-B1 METHOD FOR PRODUCING LOW-SULPHUR PETROL INST FRANCAIS DU PETROLE (FR) 2011-03-23 EP disclosed
EP-1174485-B1 Process comprising two gasoline hydrodesulphurisation steps with intermediary elimination of H2S INST FRANCAIS DU PETROLE (FR) 2010-10-27 EP disclosed
WO-2010035727-A1 NOVEL PYRROLINONE DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING SAME 塩野義製薬株式会社 (JP) 2010-04-01 WO disclosed
US-20090163672-A1 END-CAPPED POLYMER CHAINS AND PRODUCTS THEREOF UNIVERSITY OF MASSACHUSETTS LOWELL (US) 2009-06-25 US disclosed
WO-2005013914-A2 HETEROARYLAMINOSULFONYLPHENYL DERIVATIVES FOR USE AS SODIUM OR CALCIUM CHANNEL BLOCKERS IN THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-02-17 WO disclosed